Sanara MedTech Inc.
Company Stats
- Market Cap
- $322.9M
- as of Sep 30, 2026
- Enterprise Value
- $353.2M
- Shares Outstanding
- 9.2M
- Free Float
- 31.4%
Income Statement
- Revenue
- $103.1M
- Operating Income
- $7.3M
- Net Income
- -$37.6M
- EBITDA
- $11.3M
- Non-cash Impairment
- $28.3M
- Revenue Growth, 3Y
- 31.0%
- FCF Margin, 3Y Avg
- -1.2%
- FCF Margin, Worst Year
- -5.4%
Cash Flow
- Free Cash Flow
- $2.2M
- FCF Yield
- 0.7%
- Owner FCF Yield
- -0.9%
Balance Sheet
- Cash & Equivalents
- $16.6M
- Total Debt
- $46.9M
- Net Debt
- $30.3M
- Net Debt / EBITDA
- 2.70x
- EV / EBITDA
- 31.40x
- Net Debt / EBIT
- 4.15x
Returns & Capital
- SBC, 3Y Avg
- $4.3M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $103.1M | $2.2M | 2.1% |
| FY2024 | $86.7M | -$229,632 | -0.3% |
| FY2023 | $65.0M | -$3.5M | -5.4% |
| FY2022 | $45.8M | -$5.7M | -12.4% |
| FY2021 | $24.1M | -$5.0M | -20.7% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 20, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Sanara MedTech Agrees to Be Acquired by MIMEDX